Antoni Riera studied chemistry at the University of Barcelona, where he did his Doctoral thesis under the supervision of Professors Fèlix Serratosa and Miquel A. Pericàs. After a post-doctoral stage at the University of Pennsylvania (Philadelphia, USA) under the supervision of Prof. Amos B. Smith III, in 1988 he returned to the Department of Organic Chemistry of the University of Barcelona as associate professor. In June 2003 he was promoted to full professor at the same university. In 2005 he joined the Institute for Research in Biomedicine (IRB Barcelona) as group leader of the Asymmetric Synthesis Group. His main area of research is organic synthesis. His group works both on synthetic methodology projects (asymmetric hydrogenation, new chiral ligands, catalysis, isomerization reactions) and on the synthesis of biologically active compounds (amino acids, aza-sugars, peptides, protein inhibitors, protein degraders, PROTACs, bioconjugation reagents). In all these fields, he is co-author of 241 publications in international journals that received 10,053 citations. He has directed or co-directed up to 34 PhD thesis (17 in the last 10 years). In 2017 he received the “Premio a la Excelencia Científica” (Scientific Excellence Award) from the Real Sociedad Española de Química (RSEQ, Spanish Royal Society of Chemistry). He is co-founder of Enantia, S.L. a spin-off company devoted to the development of new synthetic processes for pharmaceutical products. Created in 2003, it now has 35 employees, half of them with a PhD in Chemistry.
 |
H. 9:00 - Thursday - July 4th |
 |
"Synthesis of biologically active compounds. From chiral amines to protein degraders" |
 |
https://www.irbbarcelona.org/en/research/antoni-riera |